ONABOTULINUMTOXINA IS WELL TOLERATED IN CHRONIC MIGRAINE PATIENTS TAKING ORAL PREVENTIVE MEDICATIONS: LONG-TERM COMPEL ANALYSIS BY TREATMENT CYCLE

被引：0
|
作者：
Winner, Paul K. [1 ]
Blumenfeld, Andrew M. [2 ]
Eross, Eric J. [3 ]
Orejudos, Amelia [4 ]
Adams, Aubrey Manack [4 ]
Brin, Mitchell F. [4 ,5 ]
机构：
[1] Palm Beach Headache Ctr, Premiere Res Inst Palm Beach Neurol, W Palm Beach, FL USA
[2] Headache Ctr Southern Calif, Neurol Ctr, Carlsbad, CA 92011 USA
[3] Phoenix Headache Inst, Scottsdale, AZ USA
[4] Allergan Plc, Irvine, CA USA
[5] Univ Calif Irvine, Irvine, CA USA
来源：
TOXICON | 2018年 / 156卷
关键词：
Adverse events; Chronic migraine; COMPEL; Concomitant medication; OnabotulinumtoxinA; Safety;
D O I：
10.1016/j.toxicon.2018.11.274
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
264
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [11] OnabotulinumtoxinA for the Treatment of Chronic Migraine: Long-Term Outcome
    Rothrock, J. F.
    Andress-Rothrock, D.
    Scanlon, C.
    Weibelt, S.
    HEADACHE, 2011, 51 : 60 - 60
  • [12] The Long-Term Efficacy and Safety of OnabotulinumtoxinA for the Prevention of Chronic Migraine in Patients with Medication Overuse: Results of the COMPEL Study
    Tepper, S. J.
    Wilson, M.
    Orejudos, A.
    Adams, Manack A.
    Blumenfeld, A.
    HEADACHE, 2018, 58 : 93 - 94
  • [13] The long-term efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine in patients with medication overuse: results of the COMPEL study
    Tepper, S.
    Wilson, M. -C.
    Orejudos, A.
    Adams, A. Manack
    Blumenfeld, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 78 - 78
  • [14] Long-term safety and efficacy of onabotulinumtoxinA for the prevention of chronic migraine in a South Korean population: COMPEL study
    Kim, Byung-Kun
    Chu, Min Kyung
    Adams, Aubrey Manack
    Blumenfeld, Andrew M.
    NEUROLOGY ASIA, 2019, 24 (02) : 127 - 137
  • [15] Long-term treatment of chronic migraine with onabotulinumtoxinA: CLARITY pilot study
    Blumenfeld, A.
    Inocelda, A.
    Cunanan, C.
    Purdy, C.
    Dalfonso, L.
    Magar, R.
    JOURNAL OF PAIN, 2014, 15 (04): : S100 - S100
  • [16] LONG-TERM EXPERIENCE OF ONABOTULINUMTOXINA IN A LARGE SERIES OF CHRONIC MIGRAINE PATIENTS
    Lambru, G.
    Trimboli, M.
    Andreou, A. P.
    Murphy, M.
    Al-Kaisy, A.
    CEPHALALGIA, 2016, 36 : 47 - 47
  • [17] Long-Term Use and Safety of Migraine Preventive Medications
    VanderPluym, Juliana
    Evans, Randolph W.
    Starling, Amaal J.
    HEADACHE, 2016, 56 (08): : 1335 - 1343
  • [18] Responder Rates to OnabotulinumtoxinA in Patients With Chronic Migraine: A Post Hoc Analysis of the COMPEL Study
    Rothrock, John F.
    Luo, Lei
    Eross, Eric
    Sommer, Katherine
    Blumenfeld, Andrew M.
    NEUROLOGY, 2020, 94 (15)
  • [19] Long-term treatment with prucalopride is safe and well tolerated in patients with chronic constipation.
    Schneider, HR
    Otten, M
    Wurzer, H
    Van Eeghem, P
    Graf, W
    Stevens, M
    Kerstens, R
    De Pauw, M
    GASTROENTEROLOGY, 2000, 118 (04) : A1196 - A1196
  • [20] Responder Rates to OnabotulinumtoxinA in Patients With Chronic Migraine: A Post Hoc Analysis of the COMPEL Study
    Rothrock, J. F.
    Luo, L.
    Eross, E. J.
    Sommer, K.
    Blumenfeld, A. M.
    HEADACHE, 2020, 60 : 93 - 93
12345